OpenURL Connection Search

Select item for more details and to access through your institution.

Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 3, p. 677, doi. 10.1111/jdv.16893
By:
- Richard, M.‐A.;
- Lacour, J.‐P.;
- Konstantinou, M.‐P.;
- Ruer‐Mulard, M.;
- Joly, P.;
- Aractingi, S.;
- Auquier, P.;
- Pelvet, B.;
- Augustin, M.L.;
- Mahé, E.;
- Chalmers, R.J.G.
Publication type:
Article
Tattoo complications in treated and non‐treated psoriatic patients.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2020, v. 34, n. 4, p. 888, doi. 10.1111/jdv.15975
By:
- Grodner, C.;
- Beauchet, A.;
- Fougerousse, A.‐C.;
- Quiles‐Tsimaratos, N.;
- Perrot, J.‐L.;
- Barthelemy, H.;
- Parier, J.;
- Maccari, F.;
- Beneton, N.;
- Bouilly‐Auvray, D.;
- Ruer‐Mulard, M.;
- Boulard, C.;
- Jacobzone, C.;
- Thomas‐Beaulieu, D.;
- Pourchot, D.;
- Méry‐Bossard, L.;
- Chaby, G.;
- Girard, C.;
- Duval‐Modeste, A.‐B.;
- Vermersch‐Langlin, A.
Publication type:
Article
Characteristics of patients with plaque psoriasis who have discordance between Psoriasis Area Severity Index and dermatology life quality index scores.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2017, v. 31, n. 5, p. e269, doi. 10.1111/jdv.14021
By:
- Amy de la Breteque, M.;
- Beauchet, A.;
- Quiles ‐ Tsimaratos, N.;
- Estève, E.;
- Le Guyadec, T.;
- Ruer ‐ Mulard, M.;
- Maccari, F.;
- Reguiai, Z.;
- Girard, C.;
- Bastien, M.;
- Avenel ‐ Audran, M.;
- Pauwels, C.;
- Bouilly ‐ Auvray, D.;
- Sigal, M. ‐ L.;
- Mahé, E.
Publication type:
Article
Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis ( FEATURE).
Published in:
British Journal of Dermatology, 2015, v. 172, n. 2, p. 484, doi. 10.1111/bjd.13348
By:
- Blauvelt, A.;
- Prinz, J.C.;
- Gottlieb, A.B.;
- Kingo, K.;
- Sofen, H.;
- Ruer ‐ Mulard, M.;
- Singh, V.;
- Pathan, R.;
- Papavassilis, C.;
- Cooper, S.
Publication type:
Article
Childhood-onset psoriasis: association with future cardiovascular and metabolic comorbidities.
Published in:
British Journal of Dermatology, 2013, v. 169, n. 4, p. 889, doi. 10.1111/bjd.12441
By:
- Mahé, E.;
- Maccari, F.;
- Beauchet, A.;
- Lahfa, M.;
- Barthelemy, H.;
- Reguiaï, Z.;
- Beneton, N.;
- Estève, E.;
- Chaby, G.;
- Ruer‐Mulard, M.;
- Steiner, H.‐G.;
- Pauwels, C.;
- Avenel‐Audran, M.;
- Goujon‐Henry, C.;
- Descamps, V.;
- Begon, E.;
- Sigal, M.‐L.
Publication type:
Article

Found: 5

Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study.

Tattoo complications in treated and non‐treated psoriatic patients.

Characteristics of patients with plaque psoriasis who have discordance between Psoriasis Area Severity Index and dermatology life quality index scores.

Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis ( FEATURE).

Childhood-onset psoriasis: association with future cardiovascular and metabolic comorbidities.